Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Photocure ASA: Presentation at the Carnegie Nordic Healthcare Day, New York

Posted on: 05 Dec 17

Oslo, Norway, December 5, 2017 - Photocure ASA (OSE: PHO) announced today that the company will present at the Carnegie Nordic Healthcare Day, New York, on 5 December 2017. Presenter will be Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations. The slides presented will be available on Photocure's website ( in the investor relations section.

About Photocure
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at,,

Company contact:
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


Last updated on: 05/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.